EVALUATION OF A NEW ENOXAPARIN TRAUMA DOSING PROTOCOL BASED ON ANTI-XA LEVELS STRATIFIED BY BMI

被引：0
|
作者：
Yarborough, Emily [1 ]
Howitt, Robert [1 ]
Wallace, Mindy [1 ]
Faris, Janie [1 ]
机构：
[1] Carilion Roanoke Mem Hosp, Roanoke, VA USA
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1794
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RISK FACTORS FOR NONTHERAPEUTIC ANTI-XA ASSAYS IN TRAUMA PATIENTS WITH ENOXAPARIN VTE PROPHYLAXIS
    Bethea, Audis
    Samanta, Damayanti
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [32] Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
    JLF Costa
    J Ferreira
    C Teles
    F Gutierrez
    A Mesquita
    RC Costa-Filho
    [J]. Critical Care, 11 (Suppl 3):
  • [33] Current enoxaparin dosing strategies yield supratherapeutic anti-Xa activity in many elderly patients
    Leri, F
    Voyce, SJ
    Scialla, S
    Glavich, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 509A - 509A
  • [34] Standard Prophylactic Enoxaparin Dosing Leads to Inadequate Anti-Xa Levels and Increased Deep Venous Thrombosis Rates in Critically Ill Trauma and Surgical Patients DISCUSSION
    Livingston, David H.
    Malinoski, Darren J.
    Raghavendran, Krishnan
    Ochsner, Gage M., Jr.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (04): : 879 - 880
  • [35] Evaluation of a new anti-Xa heparin assay
    Davidson, S. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 996 - 996
  • [36] Development and evaluation of PEGylated Enoxaparin: A novel approach for enhanced anti-Xa activity
    Choubey, Anupam Kumar
    Dora, Chander Parkash
    Bhatt, Tara Dutt
    Gill, Manjinder Singh
    Suresh, Sarasija
    [J]. BIOORGANIC CHEMISTRY, 2014, 54 : 1 - 6
  • [37] Assessment of enoxaparin anti-Xa activity and treatment efficacy's evaluation.
    Bounda, Guy-Armel
    Hui, Hao Zhi
    Hong, Wei
    Yu, Feng
    [J]. PHARMACOTHERAPY, 2013, 33 (05): : E57 - E57
  • [38] Evaluation of anti-factor Xa concentrations using a body mass index-based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients
    O'Keefe, Mary M.
    Carver, Thomas W.
    Herrmann, David J.
    Prom, Alyson
    Hubbard, Sara
    Rein, Lisa E.
    Peppard, William J.
    [J]. PHARMACOTHERAPY, 2022, 42 (03): : 216 - 223
  • [39] Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin
    Sheredy, Shane A.
    Stone, Andrew C.
    Mostafavifar, Ahmad M.
    Mostafavifar, Lisa G.
    Smith, Rachel M.
    Doepker, Bruce A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (04) : 366 - 374
  • [40] Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
    Ebied, Alex M.
    Li, Tammy
    Axelrod, Samantha F.
    Tam, Douglas J.
    Chen, Yiqing
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 206 - 213
12345